News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
XTALPI (02228.HK) Receives Second USD19 million Payment from DoveTree
XTALPI (02228.HK), which focuses on AI-driven drug discovery, announced that its collaboration with DoveTree has progressed smoothly. One pan-cancer high-value asset has taken the ...
Reset
Send
The window will close in 5 seconds
XTALPI (02228.HK) Receives Second USD19 million Payment from DoveTree
Close
Recommend
8
Positive
13
Negative
5
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

XTALPI (02228.HK)  +0.550 (+6.832%)    Short selling $96.90M; Ratio 12.154%   , which focuses on AI-driven drug discovery, announced that its collaboration with DoveTree has progressed smoothly. One pan-cancer high-value asset has taken the lead in entering the IND-enabling study stage. In preliminary biological activity validation, it demonstrated clear target engagement effects and an excellent selectivity window. The Group has now received the second payment of USD19 million as stipulated under the definitive agreement. Both parties will further deepen cooperation in agreed hard-to-drug targets, advancing research and development including molecular glue programs, and continuously accelerating the clinical translation of candidate drugs.

Subject to the terms of the definitive agreement, the Group is eligible to receive up to USD5.89 billion in potential regulatory and commercial milestone payments, as well as potential royalties at single-digit percentage points based on annual net sales of products. (sl/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-28 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.